img

Global Cutaneous Mastocytosis Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Cutaneous Mastocytosis Market Research Report 2024

Mastocytosis is rare condition characterized by excessive accumulation of mast cells in the body tissues. Mast cells release large amounts of histamine in blood which leads to itchy skin, skin rash and hot flushes. These cells are found in skin and the lining of stomach and lungs. Mast cells accumulated in the skin is referred to as cutaneous mastocytosis. Usually affecting children, the most common symptoms of cutaneous mastocytosis is abnormal growth on the skin such as spots or blisters which can form a rash on the body. The World Health Organization (WHO) has classified cutaneous mastocytosis into three variants namely urticaria pigmentosa, diffuse cutaneous mastocytosis and solitary cutaneous mastocytosis. Besides these, there are two other forms of cutaneous mastocytosis namely nodular mastocytosis and telangiectasia macularis eruptive perstans (TMEP) which are currently under review as they are very rare form of condition.
According to MRAResearch’s new survey, global Cutaneous Mastocytosis market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Cutaneous Mastocytosis market research.
Treatment for cutaneous mastocytosis mainly aims to relieve symptoms. Therefore, medications such as antihistamines, corticosteroids, proton pump inhibitors, immunomodulators and mast cell stabilizers. Cromolyn sodium oral solution is the only FDA approved medication for the treatment of mastocytosis. However, these products are often associated with undesired side effects including hypo pigmentation, acne, skin thinning and secondary infection. With limited evidence to support their long term safety, there is a huge opportunity for novel and effective therapies.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Cutaneous Mastocytosis market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


AB Science
Novartis
BioCentury
Rarediseases
Segment by Type
Antihistamines
Corticosteroids
Proton Pump Inhibitors
Immunomodulators
Mast Cell Stabilizers

Segment by Application


Hospitals
Ambulatory Surgical Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Cutaneous Mastocytosis report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cutaneous Mastocytosis Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Antihistamines
1.2.3 Corticosteroids
1.2.4 Proton Pump Inhibitors
1.2.5 Immunomodulators
1.2.6 Mast Cell Stabilizers
1.3 Market by Application
1.3.1 Global Cutaneous Mastocytosis Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cutaneous Mastocytosis Market Perspective (2018-2033)
2.2 Cutaneous Mastocytosis Growth Trends by Region
2.2.1 Global Cutaneous Mastocytosis Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Cutaneous Mastocytosis Historic Market Size by Region (2018-2023)
2.2.3 Cutaneous Mastocytosis Forecasted Market Size by Region (2024-2033)
2.3 Cutaneous Mastocytosis Market Dynamics
2.3.1 Cutaneous Mastocytosis Industry Trends
2.3.2 Cutaneous Mastocytosis Market Drivers
2.3.3 Cutaneous Mastocytosis Market Challenges
2.3.4 Cutaneous Mastocytosis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cutaneous Mastocytosis Players by Revenue
3.1.1 Global Top Cutaneous Mastocytosis Players by Revenue (2018-2023)
3.1.2 Global Cutaneous Mastocytosis Revenue Market Share by Players (2018-2023)
3.2 Global Cutaneous Mastocytosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cutaneous Mastocytosis Revenue
3.4 Global Cutaneous Mastocytosis Market Concentration Ratio
3.4.1 Global Cutaneous Mastocytosis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cutaneous Mastocytosis Revenue in 2022
3.5 Cutaneous Mastocytosis Key Players Head office and Area Served
3.6 Key Players Cutaneous Mastocytosis Product Solution and Service
3.7 Date of Enter into Cutaneous Mastocytosis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cutaneous Mastocytosis Breakdown Data by Type
4.1 Global Cutaneous Mastocytosis Historic Market Size by Type (2018-2023)
4.2 Global Cutaneous Mastocytosis Forecasted Market Size by Type (2024-2033)
5 Cutaneous Mastocytosis Breakdown Data by Application
5.1 Global Cutaneous Mastocytosis Historic Market Size by Application (2018-2023)
5.2 Global Cutaneous Mastocytosis Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Cutaneous Mastocytosis Market Size (2018-2033)
6.2 North America Cutaneous Mastocytosis Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Cutaneous Mastocytosis Market Size by Country (2018-2023)
6.4 North America Cutaneous Mastocytosis Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cutaneous Mastocytosis Market Size (2018-2033)
7.2 Europe Cutaneous Mastocytosis Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Cutaneous Mastocytosis Market Size by Country (2018-2023)
7.4 Europe Cutaneous Mastocytosis Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cutaneous Mastocytosis Market Size (2018-2033)
8.2 Asia-Pacific Cutaneous Mastocytosis Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Cutaneous Mastocytosis Market Size by Region (2018-2023)
8.4 Asia-Pacific Cutaneous Mastocytosis Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cutaneous Mastocytosis Market Size (2018-2033)
9.2 Latin America Cutaneous Mastocytosis Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Cutaneous Mastocytosis Market Size by Country (2018-2023)
9.4 Latin America Cutaneous Mastocytosis Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cutaneous Mastocytosis Market Size (2018-2033)
10.2 Middle East & Africa Cutaneous Mastocytosis Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Cutaneous Mastocytosis Market Size by Country (2018-2023)
10.4 Middle East & Africa Cutaneous Mastocytosis Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AB Science
11.1.1 AB Science Company Detail
11.1.2 AB Science Business Overview
11.1.3 AB Science Cutaneous Mastocytosis Introduction
11.1.4 AB Science Revenue in Cutaneous Mastocytosis Business (2018-2023)
11.1.5 AB Science Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Cutaneous Mastocytosis Introduction
11.2.4 Novartis Revenue in Cutaneous Mastocytosis Business (2018-2023)
11.2.5 Novartis Recent Development
11.3 BioCentury
11.3.1 BioCentury Company Detail
11.3.2 BioCentury Business Overview
11.3.3 BioCentury Cutaneous Mastocytosis Introduction
11.3.4 BioCentury Revenue in Cutaneous Mastocytosis Business (2018-2023)
11.3.5 BioCentury Recent Development
11.4 Rarediseases
11.4.1 Rarediseases Company Detail
11.4.2 Rarediseases Business Overview
11.4.3 Rarediseases Cutaneous Mastocytosis Introduction
11.4.4 Rarediseases Revenue in Cutaneous Mastocytosis Business (2018-2023)
11.4.5 Rarediseases Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Cutaneous Mastocytosis Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Antihistamines
Table 3. Key Players of Corticosteroids
Table 4. Key Players of Proton Pump Inhibitors
Table 5. Key Players of Immunomodulators
Table 6. Key Players of Mast Cell Stabilizers
Table 7. Global Cutaneous Mastocytosis Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Cutaneous Mastocytosis Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global Cutaneous Mastocytosis Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Cutaneous Mastocytosis Market Share by Region (2018-2023)
Table 11. Global Cutaneous Mastocytosis Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 12. Global Cutaneous Mastocytosis Market Share by Region (2024-2033)
Table 13. Cutaneous Mastocytosis Market Trends
Table 14. Cutaneous Mastocytosis Market Drivers
Table 15. Cutaneous Mastocytosis Market Challenges
Table 16. Cutaneous Mastocytosis Market Restraints
Table 17. Global Cutaneous Mastocytosis Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Cutaneous Mastocytosis Market Share by Players (2018-2023)
Table 19. Global Top Cutaneous Mastocytosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cutaneous Mastocytosis as of 2022)
Table 20. Ranking of Global Top Cutaneous Mastocytosis Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Cutaneous Mastocytosis Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Cutaneous Mastocytosis Product Solution and Service
Table 24. Date of Enter into Cutaneous Mastocytosis Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Cutaneous Mastocytosis Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Cutaneous Mastocytosis Revenue Market Share by Type (2018-2023)
Table 28. Global Cutaneous Mastocytosis Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 29. Global Cutaneous Mastocytosis Revenue Market Share by Type (2024-2033)
Table 30. Global Cutaneous Mastocytosis Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Cutaneous Mastocytosis Revenue Market Share by Application (2018-2023)
Table 32. Global Cutaneous Mastocytosis Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 33. Global Cutaneous Mastocytosis Revenue Market Share by Application (2024-2033)
Table 34. North America Cutaneous Mastocytosis Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. North America Cutaneous Mastocytosis Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Cutaneous Mastocytosis Market Size by Country (2024-2033) & (US$ Million)
Table 37. Europe Cutaneous Mastocytosis Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 38. Europe Cutaneous Mastocytosis Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Cutaneous Mastocytosis Market Size by Country (2024-2033) & (US$ Million)
Table 40. Asia-Pacific Cutaneous Mastocytosis Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 41. Asia-Pacific Cutaneous Mastocytosis Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Cutaneous Mastocytosis Market Size by Region (2024-2033) & (US$ Million)
Table 43. Latin America Cutaneous Mastocytosis Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Latin America Cutaneous Mastocytosis Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Cutaneous Mastocytosis Market Size by Country (2024-2033) & (US$ Million)
Table 46. Middle East & Africa Cutaneous Mastocytosis Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 47. Middle East & Africa Cutaneous Mastocytosis Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Cutaneous Mastocytosis Market Size by Country (2024-2033) & (US$ Million)
Table 49. AB Science Company Detail
Table 50. AB Science Business Overview
Table 51. AB Science Cutaneous Mastocytosis Product
Table 52. AB Science Revenue in Cutaneous Mastocytosis Business (2018-2023) & (US$ Million)
Table 53. AB Science Recent Development
Table 54. Novartis Company Detail
Table 55. Novartis Business Overview
Table 56. Novartis Cutaneous Mastocytosis Product
Table 57. Novartis Revenue in Cutaneous Mastocytosis Business (2018-2023) & (US$ Million)
Table 58. Novartis Recent Development
Table 59. BioCentury Company Detail
Table 60. BioCentury Business Overview
Table 61. BioCentury Cutaneous Mastocytosis Product
Table 62. BioCentury Revenue in Cutaneous Mastocytosis Business (2018-2023) & (US$ Million)
Table 63. BioCentury Recent Development
Table 64. Rarediseases Company Detail
Table 65. Rarediseases Business Overview
Table 66. Rarediseases Cutaneous Mastocytosis Product
Table 67. Rarediseases Revenue in Cutaneous Mastocytosis Business (2018-2023) & (US$ Million)
Table 68. Rarediseases Recent Development
Table 69. Research Programs/Design for This Report
Table 70. Key Data Information from Secondary Sources
Table 71. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cutaneous Mastocytosis Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Cutaneous Mastocytosis Market Share by Type: 2022 VS 2033
Figure 3. Antihistamines Features
Figure 4. Corticosteroids Features
Figure 5. Proton Pump Inhibitors Features
Figure 6. Immunomodulators Features
Figure 7. Mast Cell Stabilizers Features
Figure 8. Global Cutaneous Mastocytosis Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 9. Global Cutaneous Mastocytosis Market Share by Application: 2022 VS 2033
Figure 10. Hospitals Case Studies
Figure 11. Ambulatory Surgical Centers Case Studies
Figure 12. Others Case Studies
Figure 13. Cutaneous Mastocytosis Report Years Considered
Figure 14. Global Cutaneous Mastocytosis Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 15. Global Cutaneous Mastocytosis Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 16. Global Cutaneous Mastocytosis Market Share by Region: 2022 VS 2033
Figure 17. Global Cutaneous Mastocytosis Market Share by Players in 2022
Figure 18. Global Top Cutaneous Mastocytosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cutaneous Mastocytosis as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Cutaneous Mastocytosis Revenue in 2022
Figure 20. North America Cutaneous Mastocytosis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. North America Cutaneous Mastocytosis Market Share by Country (2018-2033)
Figure 22. United States Cutaneous Mastocytosis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada Cutaneous Mastocytosis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Cutaneous Mastocytosis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Cutaneous Mastocytosis Market Share by Country (2018-2033)
Figure 26. Germany Cutaneous Mastocytosis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. France Cutaneous Mastocytosis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. U.K. Cutaneous Mastocytosis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Italy Cutaneous Mastocytosis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Russia Cutaneous Mastocytosis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Nordic Countries Cutaneous Mastocytosis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Cutaneous Mastocytosis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific Cutaneous Mastocytosis Market Share by Region (2018-2033)
Figure 34. China Cutaneous Mastocytosis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Japan Cutaneous Mastocytosis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. South Korea Cutaneous Mastocytosis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Southeast Asia Cutaneous Mastocytosis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. India Cutaneous Mastocytosis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Australia Cutaneous Mastocytosis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Cutaneous Mastocytosis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America Cutaneous Mastocytosis Market Share by Country (2018-2033)
Figure 42. Mexico Cutaneous Mastocytosis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Brazil Cutaneous Mastocytosis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Cutaneous Mastocytosis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa Cutaneous Mastocytosis Market Share by Country (2018-2033)
Figure 46. Turkey Cutaneous Mastocytosis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Saudi Arabia Cutaneous Mastocytosis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. AB Science Revenue Growth Rate in Cutaneous Mastocytosis Business (2018-2023)
Figure 49. Novartis Revenue Growth Rate in Cutaneous Mastocytosis Business (2018-2023)
Figure 50. BioCentury Revenue Growth Rate in Cutaneous Mastocytosis Business (2018-2023)
Figure 51. Rarediseases Revenue Growth Rate in Cutaneous Mastocytosis Business (2018-2023)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries